Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
cns
Articles
1
From
2026-07-19 06:40:39+00
To
2026-07-19 06:40:39+00
Range
2026-07-12 20:03:27.72222+00 →
2026-07-19 20:03:27.72222+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| ada | ORG | 1 | 📊 🔍 🧲 |
| adaptive clinical trial design bloodbrain barrier cns drug development fda accelerated approval pharmacokinetics previous | ORG | 1 | 📊 🔍 🧲 |
| ai readiness starts | ORG | 1 | 📊 🔍 🧲 |
| als | ORG | 1 | 📊 🔍 🧲 |
| annex clinical corporation | ORG | 1 | 📊 🔍 🧲 |
| aria | ORG | 1 | 📊 🔍 🧲 |
| arletta pharma advances lybrido | PERSON | 1 | 📊 🔍 🧲 |
| avlayah | ORG | 1 | 📊 🔍 🧲 |
| bbb | ORG | 1 | 📊 🔍 🧲 |
| clinibiz | ORG | 1 | 📊 🔍 🧲 |
| cns | ORG | 1 | 📊 🔍 🧲 |
| cns pk | ORG | 1 | 📊 🔍 🧲 |
| csf | ORG | 1 | 📊 🔍 🧲 |
| denali | PERSON | 1 | 📊 🔍 🧲 |
| denali therapeutics | PERSON | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| hunter | NORP | 1 | 📊 🔍 🧲 |
| moe | PERSON | 1 | 📊 🔍 🧲 |
| moe alsumidaie | PERSON | 1 | 📊 🔍 🧲 |
| mps ii | PERSON | 1 | 📊 🔍 🧲 |
| nature reviews drug discovery | WORK_OF_ART | 1 | 📊 🔍 🧲 |
| plasma | GPE | 1 | 📊 🔍 🧲 |
| pmc | ORG | 1 | 📊 🔍 🧲 |
| pmc national library of medicine | ORG | 1 | 📊 🔍 🧲 |
| references deepceutix | PERSON | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 100.00 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-19 06:40:39+00 | Science |
|
The Blood-Brain Barrier Has Been Breached. Is Clinical Trial Science Ready? | Analyze | Moe Alsumidaie | 😐 neutral | 0.0748 |